Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population

Inflammatory Bowel Diseases

Volumn 11, Issue 12, 2005, Pages 1038-1043

  Takagawa, T ^a   Tamura, K ^a   Takeda, N ^a   Tomita, T ^a   Ohda, Y ^a   Fukunaga, K ^a   Hida, N ^a   Ohnishi, K ^a   Hori, K ^a   Kosaka, T ^a   Fukuda, Y ^a   Ikeuchi, H ^a   Yamamura, T ^a   Miwa, H ^a   Matsumoto, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Crohn's disease; Inflammatory bowel disease; Interleukin 18; Polymorphism; Ulcerative colitis

Indexed keywords

GAMMA INTERFERON; GENOMIC DNA; INTERLEUKIN 18; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; DNA SEQUENCE; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-18; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 27944433763     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000182868.67025.b9     Document Type: Article

References (50)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
2. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84-88.
3. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990-996.
4. Pizarro TT, Michie MH, Bentz M, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol. 1999;162:6829-6835.
5. Monteleone G, Trapasso F, Parrello T, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol. 1999;163:143-147.
6. Kanai T, Watanabe M, Okazawa A, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology. 2000;119:1514-1523.
7. Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, et al. Plasma interleukin-18 reflects severity of ulcerative colitis. World J Gastroenterol. 2005;11:605-608.
8. Chikano S, Sawada K, Shimoyama T, et al. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut. 2000;47:779-786.
9. Sivakumar PV, Westrich GM, Kanaly S, et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut. 2002;50:812-820.
10. Siegmund B, Fantuzzi G, Rieder F, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol. 2001;281:1264-1273.
11. Kanai T, Watanabe M, Okazawa A, et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology. 2001;121:875-888.
12. Ten Hove T, Corbaz A, Amitai H, et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology. 2001;121:1372-1379.
13. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 1995;378:88-91.
14. Stoll S, Muller G, Kurimoto M, et al. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol. 1997;159:298-302.
15. Udagawa N, Horwood NJ, Elliott J, et al. Interleukin-18(interferon-gamma- inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med. 1997;185:1005-1012.
16. Lundqvist C, Melgar S, Yeung MM, et al. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol. 1996;157:1926-1934.
17. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol. 2000;12:59-63.
18. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 1996;156:4274-4279.
19. Horwood NJ, Udagawa N, Elliott J, et al. Interleukin-18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest. 1998;101:595-603.
20. Dao T, Ohashi K, Kayano T, et al. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol. 1996;173:230-235.
21. Kohka H, Yoshino T, Iwagaki H, et al. Interleukin-18/interferon-gamma- inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol. 1998;64:519-527.
22. + T cells. Eur J Immunol. 2000;30:1998-2006.
23. Ishida Y, Migita K, Izumi Y, et al. The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett. 2004;569:156-160.
24. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol. 1999;162:5070-5077.
25. Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 regulates Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423-474.
26. Kalina U, Ballas K, Koyama N, et al. Genomic organization and regulation of the human interleukin-18 gene. Scand J Immunol. 2000;52:525-530.
27. Tone M, Thompson SA, Tone Y, et al. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol. 1997;159:6156-6163.
28. Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146-152.
29. Kretowski A, Mironczuk K, Karpinska A, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes. 2002;51:3347-3349.
30. Ide A, Kawasaki E, Abiru N, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun. 2004;22:73-78.
31. Heninger E, Treszl A, Kocsis I, et al. Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr. 2002;161:410-411.
32. Takada T, Suzuki E, Morohashi K, et al. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens. 2002;60:36-42.
33. Stassen NA, Breit CM, Norfleet LA, et al. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery. 2003;134:351-356.
34. Sivalingam SP, Yoon KH, Koh DR, et al. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens. 2003;62:498-504.
35. Zhang PA, Wu JM, Li Y, et al. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol. 2005;11:1594-1598.
36. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
37. Sashio H, Tamura K, Ito R, et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics. 2002;53:1020-1027.
38. Sugiura T, Kawaguchi Y, Harigai M, et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun. 2002;3:394-399.
39. Higa S, Hirano T, Mayumi M, et al. Association between interleukin-18 gene polymorphisms 105A/C and asthma. Clin Exp Allergy. 2003;33:1097-1102.
40. Novak N, Kruse S, Potreck J, et al. Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol. 2005;115:828-833.
41. Matsuzaki K, Hokari R, Kato S, et al. Differential expression of CCR5 and CRTH2 on infiltrated cells in colonie mucosa of patients with ulcerative colitis. J Gastroenterol Hepatol. 2003;18:1081-1088.
42. Nielsen OH, Kirman I, Rudiger N, et al. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003;38:180-185.
43. Kampfer H, Kalina U, Muhl H, et al. Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol. 1999;113:369-374.
44. Eaton AD, Xu D, Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology. 2003;108:196-203.
45. Coruh B, Marini M, Weber BD, et al. Evidence that IL-18 plays a protective role in an in vivo inflammatory model of epithelial damage and repair. Gastroenterology. 2001;120:A122.
46. Kozaiwa K, Sugawara K, Smith MF Jr, et al. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology. 2003;125:477-490.
47. Haus-Seuffert P, Meisterernst M. Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem. 2000;212:5-9.
48. Dailey L, Roberts SB, Heintz N. Purification of the human histon H4 gene-specific transcription factors H4TF-1 and H4TF2. Genes Dev. 1988;2:1700-1712.
49. Tamura K, Fukuda Y, Sashio H, et al. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol. 2002;37(Suppl 14):111-116.
50. Reuter BK, Pizarro TT. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? Eur J Immunol. 2004;34:2347-2355.